Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nuclear Stability03:18

Nuclear Stability

23.3K
Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters.
To hold positively charged protons together...
23.3K
Nuclear Fusion02:45

Nuclear Fusion

33.9K
The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.9K
Non-nuclear Inheritance01:29

Non-nuclear Inheritance

23.3K
Most DNA resides in the nucleus of a cell. However, some organelles in the cell cytoplasm⁠—such as chloroplasts and mitochondria⁠—also have their own DNA. These organelles replicate their DNA independently of the nuclear DNA of the cell in which they reside. Non-nuclear inheritance describes the inheritance of genes from structures other than the nucleus.
23.3K
Nuclear Transmutation03:20

Nuclear Transmutation

20.7K
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
20.7K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
Nuclear Power02:36

Nuclear Power

9.5K
Controlled nuclear fission reactions are used to generate electricity. Any nuclear reactor that produces power via the fission of uranium or plutonium by bombardment with neutrons has six components: nuclear fuel consisting of fissionable material, a nuclear moderator, a neutron source, control rods, reactor coolant, and a shield and containment system.
Nuclear Fuels
Nuclear fuel consists of a fissile isotope, such as uranium-235, which must be present in sufficient quantity to provide a...
9.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogeochemical signatures and pollution sources in limestone mining landscapes: environmental and health risk perspectives.

Environmental geochemistry and health·2026
Same author

Mutation T71R enhanced the structural stability and functional activity of wild type superoxide dismutase cloned from soil metagenome.

Gene·2026
Same author

A comparative assessment of [99mTc] HYNIC-PSMA-11 scintigraphy in prostate cancer as a potential substitute for disease evaluation with [68Ga] PSMA-11 PET/CT imaging.

Nuclear medicine communications·2026
Same author

Denoising of 4D dynamic PET images using spatiotemporal regularization with integrated temporal restoration (SPRINTER).

EJNMMI physics·2026
Same author

Multi-institutional evaluation of isocentricity on a ring-gantry linear accelerator platform with double-stacked MLCs.

Physics and imaging in radiation oncology·2026
Same author

Simultaneous quantification of donepezil and memantine by HPLC-refractive index detection for novel drug delivery systems.

BMC chemistry·2026

Related Experiment Video

Updated: Feb 5, 2026

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities

Published on: February 20, 2021

5.6K

Clinical Dosimetry Models and Pathway to Integration in Routine Nuclear Medicine Practice.

Mercy Akerele1, Baljinder Singh2, Justin Mikell1,3

  • 1Assistant Professor of Radiology, Mallinckrodt Institute of Radiology, Washington University in Saint Louis, Saint Louis, MO.

Clinical Nuclear Medicine
|February 3, 2026
PubMed
Summary

Radiopharmaceutical therapy (RPT) uses matching diagnostic and therapeutic agents for personalized cancer treatment. Molecular imaging and dosimetry enable individualized RPT dosing for optimal tumor targeting and normal tissue sparing.

Keywords:
MIRDOLINDAabsorbed dosesdosimetryradiopharmaceutical therapiestoxicity

More Related Videos

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

1.6K
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

18.9K

Related Experiment Videos

Last Updated: Feb 5, 2026

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities

Published on: February 20, 2021

5.6K
An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

1.6K
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

18.9K

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiopharmaceutical Science

Background:

  • Radiopharmaceutical therapy (RPT) is gaining interest, particularly within the theranostic framework combining diagnostic and therapeutic applications.
  • The theranostic approach typically uses a "matching pair" of radiopharmaceuticals: one for diagnosis (positron or gamma-emitting) and one for therapy (beta or alpha-emitting).
  • Variability in biodistribution, uptake, and retention can affect therapeutic effectiveness, necessitating precise application.

Purpose of the Study:

  • To review current clinical practices in RPT and dosimetry.
  • To discuss emerging radiopharmaceutical therapies for advanced-stage malignancies.
  • To highlight the role of molecular imaging in optimizing RPT.

Main Methods:

  • Utilizing molecular imaging techniques like SPECT and PET to map biodistribution and uptake of radiopharmaceuticals in tumors and normal organs.
  • Quantifying radioactivity distribution to determine tumor dose and normal organ exposure.
  • Individualizing administered radioactivity based on patient-specific factors (body habitus, lab parameters).

Main Results:

  • Molecular imaging allows for precise quantification of radiopharmaceutical distribution.
  • Dosimetry enables optimization of tumor targeting while sparing normal tissues.
  • Individualized RPT dosing can enhance therapeutic outcomes and minimize toxicity.

Conclusions:

  • RPT, especially when guided by theranostics and dosimetry, offers a promising avenue for personalized cancer treatment.
  • Molecular imaging is crucial for effective RPT planning and delivery.
  • Advanced RPT strategies show significant potential in treating advanced human malignancies.